Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05740332 · ClinicalTrials.gov registry record · Phase 4

Wet Time for a Foam Hand Sanitizer

A Phase 4 study, sponsored by Medline Industries.

Completed
Registry status
Phase 4
Development phase
46
Enrollment target

NCT05740332 is a Phase 4 study that has completed, run by Medline Industries. The registered enrollment target is 46 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05740332, a Phase 4 study, has completed, sponsored by Medline Industries.

COMPLETED
Registry status
Phase 4
Development phase
46 participants
Enrollment target

Study Summary

Hand sanitizers are a standard of hygiene requirements. They must be effective at reducing germ count on the hands while ideally providing emollients to moisturize the skin after use. Spectrum™ Advanced Hand Sanitizer Foam (70%) (hereby referred to as Spectrum Advanced Foam) kills over 99.99% of germs within 15 seconds while boasting double digit increases in hand moisture after two weeks of use. In 2002 and 2009 the Center for Disease Control and Prevention (CDC) and World Health Organization (WHO) published guidance that hands should remain wet for at least 15 seconds while being rubbed together after application of an alcohol-based hand rub, though the recommendations do not specify the volume of product to be apply. This study will evaluate the "wet time" of Spectrum Advanced Foam, which will be defined as the length of time in which the sanitizer foam stays wet on the hands while the participant rubs their hands with the foam sanitizer. The participant will first be asked to wash and dry their hands. Participants will review the appropriate hand sanitizer application steps, as detailed by the WHO guidance. Then, a 1.0 milliliter (mL) aliquot of Spectrum Advanced Foam will be dispensed from an automated dispenser to the participant's hands. The participant will be asked to rub their hands together following the WHO method for hand sanitizer application until they declare the product has dried sufficiently for the donning of medical gloves. Study personnel will measure the wet time of Spectrum Advanced foam using a stopwatch. If the 1.0 ml aliquot does not yield sufficient results to meet WHO guidelines then a 1.4 ml aliquot will be tested, however this was not the case for our study.

Interventions

  • DRUG Alcohol hand sanitizer foam

Trial Details

FieldValue
Enrollment Target 46 participants
Start Date 2022-12-12
Est. Completion 2023-01-12
Phase Phase 4

Sponsor

Medline Industries

24 total trials

What the Registry Record Tells You About NCT05740332

The ClinicalTrials.gov registry entry for NCT05740332 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medline Industries, which has 24 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Alcohol hand sanitizer foam is the first listed.

NCT05740332 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05740332 about?

NCT05740332 is a clinical study titled "Wet Time for a Foam Hand Sanitizer". Hand sanitizers are a standard of hygiene requirements. They must be effective at reducing germ count on the hands while ideally providing emollients to moisturize the skin after use. Spectrum™ Advanced Hand Sanitizer Foam (70%) (hereby referred to as Spectrum Advanced Foam) kills over 99.99% of ger...

What is the current status of trial NCT05740332?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 46 participants. The study started on 2022-12-12. Estimated completion is 2023-01-12.

What interventions are being tested in trial NCT05740332?

The interventions under investigation include: Alcohol hand sanitizer foam (DRUG).

Who is sponsoring clinical trial NCT05740332?

This trial is sponsored by Medline Industries, which has 24 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.